Diabetes linked to lung cancer in postmenopausal women

May 30, 2012
Diabetes linked to lung cancer in postmenopausal women
Postmenopausal women with diabetes are at a significantly higher risk of developing lung cancer, particularly if they require insulin therapy, according to research published online May 22 in Diabetes Care.

(HealthDay) -- Postmenopausal women with diabetes are at a significantly higher risk of developing lung cancer, particularly if they require insulin therapy, according to research published online May 22 in Diabetes Care.

Juhua Luo, Ph.D., of West Virginia University in Morgantown, and colleagues utilized data from the Women's Health Initiative study involving a total of 145,765 postmenopausal women aged 50 to 79 years, of whom 8,154 had diabetes, who were followed for an average of 11 years. A total of 2,257 cases of were diagnosed.

The researchers found that postmenopausal women with self-reported treated diabetes were 27 percent more likely to be diagnosed with lung cancer compared with women without diabetes. Furthermore, postmenopausal women with diabetes who required were 71 percent more likely to be diagnosed with lung cancer. No association between lung cancer risk and either duration of diabetes or untreated diabetes was observed.

"In this large prospective study in , women with treated diabetes, especially those requiring insulin, had significantly higher risk of lung cancer," the authors write. "The risk of lung cancer did not differ significantly by duration of diabetes."

Explore further: Lung cancer patients with diabetes show prolonged survival

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Lung cancer patients with diabetes show prolonged survival

October 17, 2011

Lung cancer patients with diabetes tend to live longer than patients without diabetes, according to a Norwegian study published in the November issue of the Journal of Thoracic Oncology, the official publication of the International ...

Recommended for you

Which diabetes drug is best?

July 19, 2016

(HealthDay)—No single drug to treat type 2 diabetes stands out from the pack when it comes to reducing the risks of heart disease, stroke or premature death, a new research review finds.

Gut bacteria imbalance increases diabetes risk

July 13, 2016

Currently, scientists think the major contributors to insulin resistance are excess weight and physical inactivity, yet ground-breaking new research by an EU funded European-Chinese team of investigators called MetaHit have ...

Team explores genetic architecture of type 2 diabetes

July 11, 2016

New research from a large international team of scientists offers a more complete picture of the genes responsible for type 2 diabetes, demonstrating that previously identified common alleles shared by many in the world are ...

Normal weight may not protect against diabetes

July 14, 2016

(HealthDay)—Type 2 diabetes has long been considered a disease of the overweight and obese, but a new study challenges that notion. It finds nearly one in five normal-weight people has prediabetes—a condition that can ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.